This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
C9 Neoantigen Monoclonal Antibody (WU13-15)
catalog :
MA5-49003
quantity :
100 ug
price :
US 626.00
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
WU13-15
reactivity :
human
application :
western blot, immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
product information
Product Type :
Antibody
Product Name :
C9 Neoantigen Monoclonal Antibody (WU13-15)
Catalog # :
MA5-49003
Quantity :
100 ug
Price :
US 626.00
Clonality :
Monoclonal
Purity :
Protein G
Host :
Mouse
Reactivity :
Human
Applications :
Flow Cytometry: 1:50, Immunocytochemistry: 1:50, Immunohistochemistry (Frozen): 1:50, Immunohistochemistry (Paraffin): 1:50, Inhibition Assays: 1:50, Western Blot: 1:50
Species :
Human
Clone :
WU13-15
Isotype :
IgG1
Storage :
4 C
Description :
C9 neoantigen is a target gene that is involved in the immune system's response to cancer cells. Neoantigens are proteins that are produced by cancer cells and are not present in normal cells. C9 neoantigen is a protein fragment that is produced when the C9 protein is broken down by enzymes in the cancer cells. The immune system recognizes these neoantigens as foreign and mounts an attack against the cancer cells. C9 neoantigen is being studied as a potential target for cancer immunotherapy, which involves using the patient's own immune system to fight cancer.
Immunogen :
The monoclonal antibody WU13-15 recognizes a neoepitope on the 61 kDa complement component C9, integrated in the terminal complement complex (TCC).
Format :
Liquid
Applications w/Dilutions :
Flow Cytometry: 1:50, Immunocytochemistry: 1:50, Immunohistochemistry (Frozen): 1:50, Immunohistochemistry (Paraffin): 1:50, Inhibition Assays: 1:50, Western Blot: 1:50
Aliases :
C9
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com
800-678-5599
headquarters: USA